Breast cancer and Low density lipoprotein increased

Summary:

Low density lipoprotein increased is found among people with Breast cancer, especially for people who are female, 60+ old.

The study analyzes which people have Low density lipoprotein increased with Breast cancer. It is created by eHealthMe based on reports of 60 people who have Breast cancer from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Breast cancer?

Breast cancer is found to be associated with 1,295 drugs and 1,665 conditions by eHealthMe. Check the latest studies of Breast cancer.

What is Low density lipoprotein increased?

Low density lipoprotein increased (cholesterol increased in blood) is found to be associated with 750 drugs and 770 conditions by eHealthMe. Check the latest studies of Low density lipoprotein increased.



On Jul, 14, 2026

60 people who have Breast Cancer and Low Density Lipoprotein Increased are studied.

Would you have Low density lipoprotein increased when you have Breast cancer?

Gender of people who have Breast Cancer and experienced Low Density Lipoprotein Increased *:

  • female: 98.33 %
  • male: 1.67 %

Age of people who have Breast Cancer and experienced Low Density Lipoprotein Increased *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 3.7 %
  • 40-49: 7.41 %
  • 50-59: 14.81 %
  • 60+: 74.07 %

Common co-existing conditions for these people *:

  1. Breast Cancer Metastatic: 6 people, 10.00%
  2. Bone Density Decreased: 6 people, 10.00%
  3. Stress And Anxiety: 5 people, 8.33%
  4. Sleep Disorder: 5 people, 8.33%
  5. Bone Loss: 4 people, 6.67%
  6. Arrhythmias (irregular heartbeat): 4 people, 6.67%
  7. Pain: 4 people, 6.67%
  8. Depression: 3 people, 5.00%
  9. Hyperlipidaemia (presence of excess lipids in the blood): 3 people, 5.00%
  10. Anaemia (lack of blood): 2 people, 3.33%

Common drugs taken by these people *:

  1. Arimidex: 17 people, 28.33%
  2. Zometa: 16 people, 26.67%
  3. Kisqali: 12 people, 20.00%
  4. Aredia: 12 people, 20.00%
  5. Tamoxifen Citrate: 11 people, 18.33%
  6. Femara: 10 people, 16.67%
  7. Afinitor: 8 people, 13.33%
  8. Metoprolol Tartrate: 5 people, 8.33%
  9. Ibrance: 5 people, 8.33%
  10. Xanax: 5 people, 8.33%

Common symptoms for these people *:

  1. High Blood Cholesterol: 41 people, 68.33%
  2. Red Blood Cell Count Decreased: 30 people, 50.00%
  3. Haematocrit Decreased: 28 people, 46.67%
  4. Haemoglobin Decreased: 28 people, 46.67%
  5. Lymphocyte Count Decreased: 28 people, 46.67%
  6. Bone Lesion (bone with abnormalities. bone lesions can result from growth formations, infections, or injuries): 23 people, 38.33%
  7. White Blood Cell Count Decreased: 17 people, 28.33%
  8. Blood Glucose Increased: 15 people, 25.00%
  9. Constipation: 14 people, 23.33%
  10. Metastases To Bone (cancer spreads to bone): 14 people, 23.33%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Low density lipoprotein increased?

- Check whether Low density lipoprotein increased is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Low density lipoprotein increased:

All the conditions that are associated with Low density lipoprotein increased:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Low density lipoprotein increased and Breast cancer, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: